Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

PFE

Pfizer Inc.

Dec 05 • 04:00PM ET

29.09

Dollar change -0.19
Percentage change -0.65	%

Healthcare • Drug Manufacturers - General • USA • NYSE

Stock Detail • Compare Perf. • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	S&P 500	P/E	15.98	EPS (ttm)	1.82	Insider Own	0.05%	Shs Outstand	5.65B	Perf Week	-2.02%
Market Cap	164.25B	Forward P/E	9.17	EPS next Y	3.17	Insider Trans	0.00%	Shs Float	5.64B	Perf Month	-6.94%
Income	10.47B	PEG	-	EPS next Q	-0.08	Inst Own	70.39%	Short Float / Ratio	1.02% / 1.86	Perf Quarter	-15.36%
Sales	68.54B	P/S	2.40	EPS this Y	-73.63%	Inst Trans	0.50%	Short Interest	57.50M	Perf Half Y	-24.19%
Book/sh	17.17	P/B	1.69	EPS next Y	82.82%	ROA	5.10%	Target Price	39.53	Perf Year	-42.86%
Cash/sh	7.82	P/C	3.72	EPS next 5Y	-12.37%	ROE	11.05%	52W Range	28.30 - 54.93	Perf YTD	-43.23%
Dividend	1.57	P/FCF	20.08	EPS past 5Y	9.24%	ROI	6.63%	52W High	-47.04%	Beta	0.59
Dividend %	5.41%	Quick Ratio	2.05	Sales past 5Y	19.72%	Gross Margin	53.10%	52W Low	2.79%	ATR	0.74
Employees	83000	Current Ratio	2.38	Sales Q/Q	-41.55%	Oper. Margin	15.38%	RSI (14)	39.43	Volatility	2.27% 2.12%
Optionable	Yes	Debt/Eq	0.66	EPS Q/Q	-128.10%	Profit Margin	15.27%	Rel Volume	1.26	Prev Close	29.28
Shortable	Yes	LT Debt/Eq	0.63	Earnings	Oct 31 BMO	Payout	29.43%	Avg Volume	30.89M	Price	29.09
Recom	2.08	SMA20	-3.07%	SMA50	-6.83%	SMA200	-19.86%	Volume	38,804,257	Change	-0.65%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-20-23	Resumed	UBS	Neutral	$36 → $34
Oct-16-23	Upgrade	Jefferies	Hold → Buy	$38 → $39
Jul-17-23	Reiterated	JP Morgan	Neutral	$45 → $41
Jul-14-23	Initiated	HSBC Securities	Buy	$50
Jun-29-23	Downgrade	Credit Suisse	Outperform → Neutral	$47 → $40
May-11-23	Downgrade	Daiwa Securities	Outperform → Neutral	$38
Mar-06-23	Initiated	Jefferies	Hold	$43
Feb-07-23	Upgrade	Daiwa Securities	Neutral → Outperform	$51
Jan-26-23	Downgrade	UBS	Buy → Neutral	$55 → $47
Jan-17-23	Downgrade	Wells Fargo	Overweight → Equal Weight	$54 → $50
Jan-04-23	Downgrade	BofA Securities	Buy → Neutral	$60
Dec-13-22	Upgrade	Goldman	Neutral → Buy	$47 → $60
Nov-18-22	Initiated	Credit Suisse	Outperform	$55
May-23-22	Initiated	SVB Leerink	Mkt Perform	$55
Apr-06-22	Resumed	Morgan Stanley	Equal-Weight	$55
Jan-05-22	Upgrade	BofA Securities	Neutral → Buy	$59 → $70
Jan-03-22	Reiterated	Bernstein	Mkt Perform	$44 → $65
Dec-20-21	Reiterated	Cowen	Outperform	$56 → $70
Dec-17-21	Initiated	Goldman	Neutral	$51
Dec-13-21	Upgrade	UBS	Neutral → Buy	$52 → $60

Show Previous Ratings

Today 02:06PM	While Pfizer Faced A Setback, Altimmune, Roche And Mainz Biomed Advanced in The Battle Against Obesity And Colorectal Cancer (Benzinga)
01:45PM	Pfizers Weight-Loss Pill Disappointment Is an Opening for Biotech Rivals (Barrons.com)
01:36PM	Pfizers Obesity Pill Disappointed. Biotech Rivals Are Rubbing Their Hands. (Barrons.com)
01:33PM	Arvinas and Pfizer Announce Interim Data from Phase 1b Trial of Vepdegestrant in Combination with Palbociclib (IBRANCE ) and Plans to Expand Vepdegestrant Development Program (GlobeNewswire)
11:15AM	12 Best Healthcare Dividend Stocks To Buy Now (Insider Monkey)
06:32AM	Loading…
06:32AM	Pfizer, after delay, completes enrollment in Lyme vaccine trial (BioPharma Dive)
Dec-04-23 04:20PM	Pfizer and Valneva Complete Recruitment for Phase 3 VALOR Trial for Lyme Disease Vaccine Candidate, VLA15 (GlobeNewswire)
05:32AM	Pfizer (PFE) Stock Down 5% as Obesity Drug Fails in Phase II (Zacks)
Dec-03-23 09:04PM	ProPicks: Beat the S&P 500 with our cutting-edge AI-powered stock selection (Investing.com)
05:00AM	Is Pfizer Stock a Buy Now? (Motley Fool)
Dec-02-23 02:00PM	Why I'm Considering Selling Pfizer for Tax-Loss Harvesting Purposes (Motley Fool)
08:30AM	An Important History Lesson for Gene-Editing Investors (Motley Fool)
05:00AM	5 Top Stocks to Buy Before 2024 (Motley Fool)
Dec-01-23 06:40PM	Expectations for Pfizer have been low, says Mizuho's Jared Holz on weight-loss pill setback (CNBC TV) -5.12%
04:40PM	S&P 500 Gains and Losses Today: Ulta Has a Beauty of an Earnings Report (Investopedia)
04:10PM	Loading…
04:10PM	Pfizer Halts Development Of Twice-Daily Weight-Loss Drug; PFE Stock Slides (Investor's Business Daily)
04:01PM	US STOCKS-S&P 500 hits 2023 closing high as Powell strengthens peak rate bets (Reuters)
02:37PM	US STOCKS-Wall St rallies as Powell cements peak rate bets (Reuters)
02:19PM	Pfizer slumps after pulling obesity-drug study following patient reactions (TheStreet.com)
01:23PM	Pfizer abandons plans for twice-daily weight-loss pill over side effects (The Telegraph)
12:46PM	Analyst Report: Pfizer Inc. (Morningstar Research)
12:21PM	Midday Movers: Ulta Beauty and Paramount Global Rise, Pfizer and Tesla Fall (Investopedia)
12:13PM	Pfizer Shares Drop as It Ends Study of Weight-Loss Pill Due to Patient Side Effects (Investopedia)
11:51AM	Why Pfizer Stock Is Sinking Today (Motley Fool)
11:22AM	Pfizer Layoffs 2023: What to Know About the Latest PFE Job Cuts (InvestorPlace)
11:13AM	Pfizer nixes more study of twice-daily obesity pill treatment that made many patients nauseous (Associated Press Finance)
10:41AM	Pfizer stock falls, drops work on twice-daily obesity pill (Yahoo Finance Video)
10:06AM	Pfizers Weight-Loss Drug Wont Enter a Phase 3 Trial. The Stock Drops. (Barrons.com)
09:57AM	Pfizer Stock Heads for Lowest Level Since 2020 After Obesity-Drug Setback (The Wall Street Journal)
08:55AM	US STOCKS-Wall St set for lower open in run-up to Powell's remarks (Reuters)
08:51AM	Loading…
08:51AM	Pfizer drops plan for twice-daily obesity pill due to side effects (Financial Times)
08:38AM	Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects (CNBC TV)
08:04AM	Pfizer slumps; pulls 2-dose obesity-drug study following patient reactions (TheStreet.com)
07:57AM	Pfizer cans twice-daily oral obesity program after half of patients leave trial while once daily continues (FierceBiotech.com)
07:23AM	US STOCKS-Futures muted as caution prevails in run-up to Powell's remarks (Reuters)
06:45AM	Pfizer Announces Topline Phase 2b Results of Oral GLP-1R Agonist, Danuglipron, in Adults with Obesity (Business Wire)
Nov-30-23 08:35PM	Lightning Round: I'm calling the bottom on Pfizer, says Jim Cramer (CNBC TV)
05:16PM	UPDATE 2-Pfizer is sued by Texas over COVID vaccine claims (Reuters)
03:44PM	Pfizer is sued by Texas over COVID-19 vaccine claims (Reuters)
11:30AM	Why Is Pfizer (PFE) Down 1.4% Since Last Earnings Report? (Zacks)
11:04AM	UPDATE 1-Turkey launches investigation into 19 pharma companies (Reuters)
09:35AM	5 Stocks under $50 to Buy and Hold Forever (Insider Monkey)
08:01AM	5 Best Stocks Under $50 To Buy Now (Insider Monkey)
07:00AM	Nobody wants to speak about COVID: Less than 3% of eligible Americans got a booster shot in September does that mean trouble for these 3 big vaccine stocks? (Moneywise)
02:13AM	Turkey launches investigation into 19 pharma companies (Reuters)
Nov-29-23 05:43PM	10 Disadvantages of Long-Term Investments (Insider Monkey)
01:01AM	Eight Beaten-Down Stocks Including Pfizer and Hasbro That Look Like Bargains (Barrons.com)
01:01AM	8 Beaten-Down Stocks, Including Pfizer and Hasbro, That Look Like Bargains (Barrons.com)
Nov-28-23 05:05PM	Arvinas and Pfizer Announce Updated Vepdegestrant (ARV-471) Data to be Presented at the 2023 San Antonio Breast Cancer Symposium (GlobeNewswire)
04:41PM	SpringWorks Therapeutics Shares Skyrocket on FDA Approval of Desmoid Tumor Drug (Investopedia)
02:36PM	12 Very High Yield Dividend Stocks With Upside Potential (Insider Monkey)
01:34PM	AWS expands big pharma partnerships on manufacturing, AI, and R&D (Yahoo Finance)
01:34PM	AWS expands big pharma partnerships in manufacturing, AI, and R&D (Yahoo Finance)
11:51AM	Pfizer disappointed in RSV shot's market share, CFO says (Reuters)
09:00AM	Here is What to Know Beyond Why Pfizer Inc. (PFE) is a Trending Stock (Zacks)
08:03AM	Merck strides onto Pfizer's turf, posting pivotal vaccine data and heading to regulators (FierceBiotech.com)
Nov-27-23 03:23PM	How To Earn $500 A Month From Pfizer Stock (Benzinga)
11:00AM	Is Pfizer Stock A Sell After Its Covid Sales 'All But Disappeared'? (Investor's Business Daily)
Nov-26-23 04:44PM	2 Biotech Stocks That Could Soar in December (Motley Fool)
02:00PM	Is Pfizer Stock a Buy Ahead of This Highly Anticipated Weight Loss Readout? (Motley Fool)
06:51AM	15 Best Drug Stocks To Invest In (Insider Monkey)
Nov-24-23 08:00AM	Is Pfizer Stock a Buy Now? (Motley Fool)
Nov-22-23 05:00AM	2 Stocks You'll Be Grateful You Bought at These Bargain Prices (Motley Fool)
Nov-21-23 03:20PM	A Golden Age of Vaccines Is Here. What It Means for You. (Barrons.com)
11:12AM	UPDATE 1-Texas AG sues Pfizer over quality-control lapses in kids' ADHD drug (Reuters)
10:00AM	Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference (Business Wire)
09:04AM	CORRECTED-UPDATE 1-European Patent Office declares Moderna mRNA patent invalid (Reuters)
05:37AM	BioNTech says European Patent Office has declared Moderna patent invalid (Reuters)
05:30AM	Ignore Eli Lilly. These 2 Stocks Are Better Buys Right Now (Motley Fool)
Nov-20-23 07:28PM	Texas AG sues Pfizer over quality-control lapses in kids' ADHD drug (Reuters)
06:52AM	20 Most Valuable Healthcare Companies in the World (Insider Monkey)
01:15AM	Continued strong Cresemba (isavuconazole) sales performance in Asia Pacific and China triggers third sales milestone payment for the region from Pfizer this year (GlobeNewswire)
Nov-17-23 06:36PM	Final Trades: Marathon Petroleum, Coca-Cola, Retail, Pfizer (CNBC TV)
11:32AM	Why the Cheapest Stock in the S&P 500 Is No Bargain (Barrons.com)
10:21AM	14 Value Stocks to Buy With High Dividend Yields (Insider Monkey)
09:00AM	Is Trending Stock Pfizer Inc. (PFE) a Buy Now? (Zacks)
08:35AM	3 Key Trends to Consider in Ginkgo Bioworks' Q3 Earnings Report (Motley Fool)
Nov-16-23 10:33PM	Pfizer and Astellas' XTANDI Approved by U.S. FDA in Earlier Prostate Cancer Treatment Setting (PR Newswire)
12:13PM	10 States With The Most Doctors Per Capita In 2023 (Insider Monkey)
08:39AM	Pfizer's (PFE) New Products May Drive Long-Term Sales Growth (Zacks)
05:00AM	AbbVie and Pfizer Have 1 Thing in Common: Their Biggest Products Are on the Decline. Time to Sell? (Motley Fool)
02:00AM	Pharma Is Out of Favor. 5 Drug Stocks With Room to Grow. (Barrons.com)
Nov-15-23 07:03PM	50 Most Populated Countries in 2030 (Insider Monkey)
Nov-14-23 04:19PM	Earnings Estimates Are Falling. These Two Companies Are Shouldering the Blame. (The Wall Street Journal)
03:36PM	10 Best Performing Healthcare ETFs in 2023 (Insider Monkey)
03:12PM	Pfizer Layoffs 2023: What to Know About the Latest PFE Job Cuts (InvestorPlace)
01:13PM	Pfizer to cut 500 jobs at UK factory as demand for Covid jab slumps (The Telegraph)
12:30PM	The S&P 500 Has Two Companies to Thank for the Slide in Earnings Estimates (The Wall Street Journal)
10:39AM	UPDATE 1-Pfizer to cut 500 jobs in UK (Reuters)
10:26AM	Pfizer to cut 500 jobs at UK site as part of wider cost cuts (Reuters)
10:23AM	Pfizer to cut 500 jobs at Kent site - Sky News (Reuters)
09:45AM	Better Growth Stock: Pfizer vs. Novo Nordisk (Motley Fool)
01:30AM	AstraZeneca Targets New Pill as Cheaper Option for Losing a Bit of Weight (Barrons.com)
Nov-13-23 09:50PM	Jim Simons Stock Portfolio: 12 Biggest Healthcare Stocks (Insider Monkey)
04:28PM	16 Stocks Hedge Funds and Wall Street Analysts Are Crazy About (Insider Monkey)
02:56PM	10 Healthcare Focused Hedge Funds and 10 Top Stock Picks (Insider Monkey)
05:51AM	Basilea continues pipeline fill up by paying Pfizer $37M for Amplyx antifungal (FierceBiotech.com)
Nov-12-23 05:30AM	3 Stocks That Can Benefit from a Santa Claus Rally (Motley Fool)
Nov-11-23 10:25AM	Valneva SE (NASDAQ:VALN) Q3 2023 Earnings Call Transcript (Insider Monkey)
05:30AM	Where Will Novavax Be in 3 Years? (Motley Fool)

Pfizer Inc. is a research-based global biopharmaceutical company. It engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Gottlieb Scott	Director	May 08	Buy	38.58	1,000	38,580	6,000	May 09 04:17 PM
Gottlieb Scott	Director	May 05	Buy	38.42	1,000	38,425	5,000	May 09 04:17 PM
PFIZER INC	10% Owner	Mar 17	Buy	2.76	1,811,594	4,999,999	5,952,263	Mar 21 06:07 PM
DAMICO JENNIFER B.	SVP & Controller	Mar 15	Sale	40.02	9,912	396,678	9,003	Mar 17 04:53 PM
SUSMAN SALLY	Executive Vice President	Feb 25	Option Exercise	22.89	72,984	1,670,604	209,179	Feb 28 05:52 PM
JOHNSON RADY A	Executive Vice President	Feb 25	Option Exercise	22.89	33,654	770,340	116,473	Feb 28 05:52 PM
Hwang Angela	President, Global Biopharma	Feb 25	Option Exercise	22.89	20,273	464,049	44,541	Feb 28 05:52 PM
McDermott Michael	Executive Vice President	Feb 25	Option Exercise	22.89	14,178	324,534	93,099	Feb 28 05:52 PM
DAMICO JENNIFER B.	SVP & Controller	Feb 25	Option Exercise	22.89	11,150	255,224	27,893	Feb 28 05:52 PM
SUSMAN SALLY	Executive Vice President	Feb 22	Option Exercise	30.17	76,043	2,294,217	195,493	Feb 24 09:17 PM
Hwang Angela	President, Global Biopharmaceu	Feb 22	Option Exercise	30.17	57,032	1,720,655	67,027	Feb 24 09:34 PM
JOHNSON RADY A	Executive Vice President	Feb 22	Option Exercise	30.17	31,558	952,105	106,556	Feb 24 08:27 PM
SAHNI PAYAL	Executive Vice President	Feb 22	Option Exercise	30.17	15,209	458,856	32,671	Feb 24 09:03 PM
McDermott Michael	Executive Vice President	Feb 22	Option Exercise	30.17	13,307	401,472	88,957	Feb 24 08:52 PM
DAMICO JENNIFER B.	SVP & Controller	Feb 22	Option Exercise	30.17	10,456	315,458	21,584	Feb 24 08:14 PM
BOURLA ALBERT	Chairman & CEO	Dec 16	Option Exercise	27.25	222,328	6,058,580	411,890	Dec 16 06:14 PM
LANKLER DOUGLAS M	Executive Vice President	Dec 14	Option Exercise	26.29	101,658	2,672,548	180,461	Dec 16 06:14 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

PFE

Pfizer Inc.

Upgrade your FINVIZ experience